Chapters: 00:09 Intro, Cold Weather Banter & Podcast Upgrades 06:40 Kisspeptin Overview: How It Works for Fertility 10:45 Kisspeptin for Men vs Women (Hormones, Ovulation, Libido) 11:10 Why Kisspeptin Doesnt Work on TRT 12:00 HCG vs Kisspeptin for Fertility on TRT 20:00 Kisspeptin Dosing, Frequency & Shutdown Risk 26:20 Thymosin Alpha-1: Immune System Master Peptide 30:10 Autoimmune Benefits, Inflammation & Cancer Support 31:00 TA-1 for Travel, Illness & Real-World Use 32:45 TA-1 Dosing Protocols & When to Run It 34:50 Sleep, Recovery & Why Most People Stay Sick 39:40 Botox, Snap-8 & TMJ Side Discussion 40:50 Future Podcast Plans, Guest Doctors & Outro We cover: Kisspeptin The fertility signal peptide Activates the hypothalamus GnRH pituitary LH & FSH cascade Drives natural testosterone production in men Stimulates sperm production and fertility In women: supports follicle development, ovulation, estrogen & progesterone Powerful tool for pre-pregnancy hormone optimization Does NOT work while on TRT (HPTA is suppressed) TRT fertility reality check Why exogenous testosterone shuts down the fertility signal HCG as the primary on-TRT fertility solution Real-world success using 1,000 IU 3x/week protocols HMG: the true LH + FSH option (but high cost) Thymosin Alpha-1 The immune system commander Trains and multiplies T-helper & T-killer cells Enhances pathogen detection and destruction Immune modulation (not just stimulation) Reduces systemic inflammation Supports autoimmune balance Used globally for hepatitis, sepsis, cancer support & viral defense Why TA-1 is the travel essential Massive reduction in getting sick from flights Rapid recovery when illness starts Ideal stacked with glutathione & B-12 for immune response Inflammation & autoimmune applications Helps regulate overactive immune response Can improve chronic inflammatory conditions Individual response matters trial and feedback is key Whether your goal is having a child, restoring natural hormone signaling, staying healthy while traveling, or building a bulletproof immune system these two peptides attack the problem at the root
CONGENITAL MELANOCYTIC NEVI Congenital melanocytic nevi (CMN) are classically defined as melanocytic nevi present at birth or within the first few months of life, and they can be observed in approximately 2% of neonates
Wipe your work surface with an alcohol swab or clean towel
LLMs are moving away from quantity-based sourcing toward intent-based citation, and community content only makes the cut because there are simply no better answers out there
An open-label trial by Mansur et al 23 reported that addition of liraglutide 1.8 mg daily to the existing medication regimen led to significant increases from baseline to week 4 in the Trail-Making Test-B standard score and in a composite Z-score comprising multiple cognitive tests
Xu et al., 2015
